Targeting PID1 generates oxysterols to switch macrophage cell fates for improved antitumor immunity
- 16 June 2026
- journal article
- research article
- Published by Springer Nature in Nature Cancer
- Vol. 7 (9) , 1-18
Abstract
Disordered cholesterol–oxysterol profiles are observed in the tumor microenvironment, yet their roles in tumor-associated macrophages (TAMs) remain underexplored. This study reveals that TAMs across human pan-cancers exhibit elevated phosphotyrosine interaction domain-containing protein 1 (PID1) expression and prominent immunosuppressive gene signatures. PID1 deficiency in myeloid cells upregulates low-density lipoprotein (LDL) receptor expression, thereby promoting LDL uptake and intracellular accumulation of free cholesterol and reactive oxygen species (ROS). Increased ROS drives cholesterol oxidation to generate the oxysterols 5α,6α-epoxycholesterol (5α,6α-EC) and 7β-hydroxycholesterol (7β-OHC), which inhibit mTOR–STAT6 signaling in macrophages. Pid1 deletion switches immunosuppressive macrophages toward an antitumor subtype that downregulates arginase 1 expression while upregulating proinflammatory cytokines, thereby potentiating CD8+ T cell-mediated immunosurveillance across multiple tumor types. Moreover, combination treatment with the oxysterol and chemotherapeutic agent 5-fluorouracil produces synergistically enhanced antitumor effects. Previous studies showed that cholesterol-derived oxysterols differentially regulate macrophage cell fates, with 25-OHC promoting the protumor and immunosuppressive phenotype of TAMs. Targeting PID1 reroutes cholesterol and ROS metabolism toward the production of 5α,6α-EC and 7β-OHC in TAMs, representing a promising immunometabolic strategy to restore antitumor immunosurveillance.Keywords
This publication has 70 references indexed in Scilit:
- Outer Membrane Vesicle‐Based Nanohybrids Target Tumor‐Associated Macrophages to Enhance Trained Immunity‐Related Vaccine‐Generated Antitumor ActivityAdvanced Materials, 2023
- Comprehensive metabolite quantitative assay based on alternate metabolomics and lipidomics analysesAnalytica Chimica Acta, 2022
- Attenuation of 7-ketocholesterol- and 7β-hydroxycholesterol-induced oxiapoptophagy by nutrients, synthetic molecules and oils: Potential for the prevention of age-related diseasesAgeing Research Reviews, 2021
- Acceptor Engineering for Optimized ROS Generation Facilitates Reprogramming Macrophages to M1 Phenotype in Photodynamic ImmunotherapyAngewandte Chemie International Edition, 2020
- Overexpression of PID1 reduces high density lipoprotein level and functionality in swineIUBMB Life, 2019
- T Cell Dysfunction in CancerCancer Cell, 2018
- 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of Tamoxifen in breast cancer cellsBiochemical Pharmacology, 2013
- Lipid homeostasis and the formation of macrophage-derived foam cells in atherosclerosisProtein & Cell, 2012
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathwaysHepatology, 2011
- Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytesMolecular and Cellular Biochemistry, 2010